$ATOS ATOSSA THERAPEUTICS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ATOSSA THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ATOSSA THERAPEUTICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ATOSSA THERAPEUTICS, INC. for free.
IRS Number: 264753208
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ATOS
Company Address: 107 SPRING STREET SEATTLE 98104
Phone number: 206 325 6086
Former name: ATOSSA GENETICS INC, date of change: 2010-03-25
Market Capitalization: $6.08M
Prev close: $1.81
Average Daily Volume: 150,206
Days Low: $1.56
Year Low: $1.30
Year High: $10.65
ATOSSA THERAPEUTICS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 18 2021 | ATOS | ATOSSA THERAPEUTIC ... | Remmel H. Lawrence | Director | Option Exercise | A | 2.90 | 50,000 | 145,000 | 50,000 | |
| May 18 2021 | ATOS | ATOSSA THERAPEUTIC ... | WEAVER GREGORY L | Director | Option Exercise | A | 2.90 | 50,000 | 145,000 | 50,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | Remmel H. Lawrence | Director | Option Exercise | A | 1.70 | 45,000 | 76,500 | 45,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | WEAVER GREGORY L | Director | Option Exercise | A | 1.70 | 70,000 | 119,000 | 70,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | Steinhart Richard I | Director | Option Exercise | A | 1.70 | 45,000 | 76,500 | 45,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | Chen Shu-Chih | Director | Option Exercise | A | 1.70 | 45,000 | 76,500 | 45,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | Galli Stephen J | Director | Option Exercise | A | 1.70 | 45,000 | 76,500 | 45,000 | |
| Apr 13 2020 | ATOS | ATOSSA THERAPEUTIC ... | Guse Kyle | CFO, Gen Counsel an ... | Option Exercise | A | 1.48 | 395,000 | 584,600 | 395,000 | |
| Apr 13 2020 | ATOS | ATOSSA THERAPEUTIC ... | Guse Kyle | CFO, Gen Counsel an ... | Option Exercise | A | 1.48 | 195,000 | 288,600 | 195,000 | |
| Apr 13 2020 | ATOS | ATOSSA THERAPEUTIC ... | QUAY STEVEN C | President & CEO | Option Exercise | A | 1.48 | 1,305,000 | 1,931,400 | 1,305,000 | |
| Apr 13 2020 | ATOS | ATOSSA THERAPEUTIC ... | QUAY STEVEN C | President & CEO | Option Exercise | A | 1.48 | 195,000 | 288,600 | 195,000 | |
| May 21 2019 | ATOS | ATOSSA GENETICS IN ... | WEAVER GREGORY L | Director | Option Exercise | A | 2.52 | 45,000 | 113,400 | 45,000 | |
| May 21 2019 | ATOS | ATOSSA GENETICS IN ... | Steinhart Richard I | Director | Option Exercise | A | 2.52 | 45,000 | 113,400 | 45,000 | |
| May 21 2019 | ATOS | ATOSSA GENETICS IN ... | Galli Stephen J | Director | Option Exercise | A | 2.52 | 45,000 | 113,400 | 45,000 | |
| May 21 2019 | ATOS | ATOSSA GENETICS IN ... | Remmel H. Lawrence | Director | Option Exercise | A | 2.52 | 45,000 | 113,400 | 45,000 |